Oral progestins and regression of carcinoma in situ and cervical dysplasia. A cytologic evaluation.
D000293:Adolescent; D000328:Adult; D002277:Carcinoma / Q000188:drug therapy; D002584:Cervix Uteri / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008656:Mestranol / Q000627:therapeutic use*; D009641:Norethynodrel / Q000627:therapeutic use*; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology
D003276:Contraceptives, Oral; D009641:Norethynodrel; D008656:Mestranol